Form 4: Clover Health Exec Sells Shares for Tax Withholding

Clover Health Investments Corp. CEO Jamie L. Reynoso sold shares to cover tax obligations related to restricted stock unit vesting.

Summary

• Jamie L. Reynoso, CEO of Medicare Advantage at Clover Health Investments, Corp., sold 6,229 shares of Class A Common Stock on July 6, 2026.
• The sale was executed at a price of $5.26 per share.
• These shares were sold to cover tax withholding obligations associated with the vesting of 6.25% of restricted stock units (RSUs) granted on January 3, 2023.
• The transaction was a mandatory 'sell to cover' as per the company's equity incentive plan, not a discretionary trade.
• Reynoso retains beneficial ownership of 2,834,982 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale can be perceived negatively, the clear explanation of it being a mandatory 'sell to cover' for tax obligations mitigates significant concern.

Positives

• The sale was a mandatory 'sell to cover' transaction to satisfy tax obligations, indicating compliance with company policy and tax requirements.
• The reporting person, Jamie L. Reynoso, continues to hold a significant number of shares (2,834,982) directly, suggesting ongoing commitment to the company.

Negatives

• The sale of shares, even if mandatory, reduces the reporting person's direct holdings, which could be perceived negatively by the market.
• The transaction price of $5.26 per share is noted, but without prior or subsequent trading prices, its significance is unclear.

Risks

• The remaining RSUs vest quarterly until January 1, 2027, implying potential for future 'sell to cover' transactions if tax obligations arise from further vesting.
• The company's reliance on 'sell to cover' transactions for tax withholding could indicate a cash flow situation where executives do not have readily available funds to cover these obligations.

Future Outlook

The remaining RSUs will continue to vest quarterly in equal installments of 6.25% until January 1, 2027, subject to continued service. This implies that further 'sell to cover' transactions may occur to satisfy tax withholding obligations upon future vesting events.

Management Comments

• The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the "RSUs") on July 3, 2026.
• These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Industry Context

StockSavvy.ai notes that insider sales for tax withholding are common, especially when stock-based compensation is a significant part of executive compensation. However, the frequency and volume of such sales can be a point of scrutiny for investors, particularly if the company's stock price is under pressure.

Stakeholder Impact

• Shareholders: The sale reduces the direct ownership of a key executive, which could be a minor concern, but the mandatory nature of the sale for tax purposes lessens the negative impact.
• Employees: The transaction highlights the company's equity incentive plans and the tax implications for executives, reinforcing the structure of executive compensation.
• Management: The transaction demonstrates adherence to the company's equity incentive plan and tax compliance requirements.

Next Steps

• Continued vesting of RSUs on a quarterly basis until January 1, 2027.
• Potential future 'sell to cover' transactions to satisfy tax withholding obligations upon subsequent vesting events.

Key Dates

Recommendation

This Form 4 filing details a mandatory sale of shares by an executive to cover tax obligations related to RSU vesting. It is not a discretionary trade and the executive retains a substantial number of shares. Therefore, it does not provide new information that would warrant a change in investment strategy, suggesting a 'hold' position.

Keywords

Form 4, Insider Trading, Clover Health Investments, CLOV, Jamie L. Reynoso, Stock Sale, Tax Withholding, Restricted Stock Units, RSUs, Vesting, CEO, Medicare Advantage